Displaying items by tag: division of pulmonary allergy and critical care medicine

Funded by the National Institutes of Health, HEALTHe Birmingham will measure the effects of community revitalization on residents’ health.
By showing a critical role for sialylation in the biophysical properties of mucus and mucus transport, the study identifies a possible therapeutic target for the treatment of cystic fibrosis and other muco-obstructive diseases.
Whitfield’s eight-bed ICU is monitored remotely 24/7 by the UAB Tele-ICU team to help support the bedside staff.
The study will observe two sedation medications, ketamine and etomidate, that are most commonly used for sedations, ketamine and etomidate, to determine which is best during intubations.
Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements after treatment with the monoclonal antibody dupilumab.
Cure HHT has named the HHT Clinic at UAB Hospital a Center of Excellence. Only hospitals equipped with the proper personnel, expertise, commitment and resources to provide comprehensive evaluation, treatment and education to individuals with HHT and their families receive this designation.
Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab.
Description of this mechanism offers a promising therapeutic target to limit lung injury and death. Lower respiratory tract infections, including bacterial pneumonia, are the fourth-leading cause of death worldwide, with 120 million to 156 million cases and 1.4 million deaths a year.
Patients suffering from cystic fibrosis often struggle with malnutrition, due to the disease’s impact on the digestive system and the increased energy needs of the body.
Bhatt serves as the medical director of the UAB Pulmonary Function and Exercise Physiology Lab and the UAB Pulmonary Rehabilitation Program.
Page 1 of 7